EIP Resources

Publications

MPS
MLD
AM
Equity

Advances in gene therapy for MLD and MPS I

Institute of Pediatrics

Smell and taste disorders in children with MPS

Institute of Pediatrics

Short stature as a symptom of attenuated MPS I

Institute of Pediatrics

The new frame for Mucopolysaccharidoses

Institute of Pediatrics

Genotype-phenotype insights in MPS I from the International Registry

Institute of Pediatrics

Open issues in Mucopolysaccharidosis type I-Hurler

Institute of Pediatrics

Mucopolysaccharidosis Type I

Institute of Pediatrics

ENT and mucopolysaccharidoses

Institute of Pediatrics

Why should rheumatologists be aware of the mucopolysaccharidoses?

Institute of Pediatrics

Hip morphology in children with MPS I and II

Institute of Pediatrics

Musculoskeletal symptoms in lysosomal storage disorders

Institute of Pediatrics

Orthopaedic challenges for mucopolysaccharidoses

Institute of Pediatrics

Growth patterns in MPS I and II children

Institute of Pediatrics

Faster MPS I diagnosis with an easy-to-use algorithm

Institute of Pediatrics

Early diagnostic signs of mucopolysaccharidoses in infants

Institute of Pediatrics

Clinical hints for diagnosing attenuated MPS forms

Institute of Pediatrics

Growth impairment review in mucopolysaccharidoses

Institute of Pediatrics

Height, weight and BMI in Taiwanese MPS patients

Institute of Pediatrics

Otolaryngologists' role in early MPS diagnosis

Institute of Pediatrics

Time to treatment improvement in MPS I, but not diagnosis

Institute of Pediatrics

ENT symptoms in 61 patients with mucopolysaccharidosis

Institute of Pediatrics

Mucopolysaccharidosis in Southern and Eastern Europe

Institute of Pediatrics

Gene therapy progress for metachromatic leukodystrophy

Institute of Pediatrics

Advances in gene therapy for MLD and MPS I

Institute of Pediatrics

Leukodystrophies: a proposed classification system

Institute of Pediatrics

Peripheral neuropathy in metachromatic leukodystrophy

Institute of Pediatrics

Metachromatic leukodystrophy and transplantation

Institute of Pediatrics

Leukodystrophies in children. Diagnosis and treatment approaches

Institute of Pediatrics

Diagnosis and treatment approaches for metachromatic leukodystrophy

Institute of Pediatrics

Early paralytic strabismus in toddlers. Sign of late-infantile MLD

Institute of Pediatrics

Newborn screening for MLD. European recommendations

Institute of Pediatrics

Effectiveness and safety of MLD treatments in children

Institute of Pediatrics

Brain MRI hallmarks in alpha-mannosidosis

Institute of Pediatrics

Recognizing alpha-mannosidosis in paediatric and adult patients

Institute of Pediatrics

Alpha-Mannosidosis: A rarely diagnosed MPS-like disease

Institute of Pediatrics

Velmanase alfa treatment.Efficacy and safety in alpha-mannosidosis

Institute of Pediatrics

Long-term efficacy of velmanase alfa in alpha-mannosidosis

Institute of Pediatrics

Genotype, antibodies and velmanase alfa long-term outcomes

Institute of Pediatrics

Alpha-mannosidosis enzyme therapy: 12-month follow-up study

Institute of Pediatrics

Velmanase alfa vs transplant in moderate alpha-mannosidosis

Institute of Pediatrics

BOT-2 test for enzyme therapy efficacy in alpha-mannosidosis

Institute of Pediatrics

Velmanase alfa safety and efficacy in children under 6

Institute of Pediatrics

Long-term enzyme therapy benefits in alpha-mannosidosis

Institute of Pediatrics

Neurocognitive dysfunction and psychosis in alpha-mannosidosis

Institute of Pediatrics

Velmanase alfa response model and outcomes in alpha-mannosidosis

Institute of Pediatrics

Advances in gene therapy for MLD and MPS I

Institute of Pediatrics

Smell and taste disorders in children with MPS

Institute of Pediatrics

Short stature as a symptom of attenuated MPS I

Institute of Pediatrics

The new frame for Mucopolysaccharidoses

Institute of Pediatrics

Genotype-phenotype insights in MPS I from the International Registry

Institute of Pediatrics

Open issues in Mucopolysaccharidosis type I-Hurler

Institute of Pediatrics

Mucopolysaccharidosis Type I

Institute of Pediatrics

ENT and mucopolysaccharidoses

Institute of Pediatrics

Why should rheumatologists be aware of the mucopolysaccharidoses?

Institute of Pediatrics

Hip morphology in children with MPS I and II

Institute of Pediatrics

Musculoskeletal symptoms in lysosomal storage disorders

Institute of Pediatrics

Orthopaedic challenges for mucopolysaccharidoses

Institute of Pediatrics

Growth patterns in MPS I and II children

Institute of Pediatrics

Faster MPS I diagnosis with an easy-to-use algorithm

Institute of Pediatrics

Early diagnostic signs of mucopolysaccharidoses in infants

Institute of Pediatrics

Clinical hints for diagnosing attenuated MPS forms

Institute of Pediatrics

Growth impairment review in mucopolysaccharidoses

Institute of Pediatrics

Height, weight and BMI in Taiwanese MPS patients

Institute of Pediatrics

Otolaryngologists' role in early MPS diagnosis

Institute of Pediatrics

Time to treatment improvement in MPS I, but not diagnosis

Institute of Pediatrics

ENT symptoms in 61 patients with mucopolysaccharidosis

Institute of Pediatrics

Mucopolysaccharidosis in Southern and Eastern Europe

Institute of Pediatrics

Excellence in Pediatrics is a non-profit
global network dedicated to advancing
pediatric healthcare.

Rue des Vignerons 18, 1110 Morges 1 (VD), Switzerland

Events
EIP2025Upcoming Webinars
Resources
WebinarsResourcesNewsThink Rare ProgramMPSMLDAM
About
Our StoryCommunityMission StatementLifeCourse Prevention
Legal
Privacy PolicyCookies Policy
© 2025 Excellence in Pediatrics Insititute. All Rights Reserved.